Daiichi Sankyo has announced that Hiroyuki Okuzawa will succeed Sunao Manabe as chief executive officer from 1 April 2025.

The FDA has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults with moderate-to-severe acute pain.

During a Senate HELP Committee hearing, RFK Jr. stated that President Trump is dedicated to bringing drug manufacturing "back ...

Takeda has announced the appointment of Julie Kim as the successor to Christophe Weber, effective from June 2026.

The pathway allows medicine developers to work with the regulators, the NHS and health technology assessment bodies.

Prioritising US health, Trump has already frozen the supply of HIV and malaria medication aid to endemic countries.

Leveragen has announced a strategic partnership with Moonlight Bio, targeting the development of T-cell therapies for ...

Acellera and Psivant have announced a strategic research partnership aimed at developing computational drug discovery ...

The potential secretary for Health and Human Services has been forced to defend his previous anti-vaccine stances at his ...

Lyndra Therapeutics has announced the immediate appointment of Adam Sayer as its new president and CEO, succeeding Jessica ...

The deal includes an upfront payment of $250m, with the potential for an additional $752.5m in milestone payments.

The new indication makes Ozempic the first glucagon-like peptide-1 receptor agonist (GLP-1RA) available for people with T2D ...